Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Lamitor

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

78 API Suppliers, 33 USDMF, 22 CEP/COS, 5 JDMF, 21 EU WC, 9 KDMF, 21 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1067 FDF Dossiers, 230 FDA Orange Book, 597 Europe, 38 Canada, 58 Australia, 72 South Africa, 72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Evonik, 5 Rochem International Inc, 23 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

102 Fillers, Diluents & Binders, 81 Coating Systems & Additives, 50 Disintegrants & Superdisintegrants, 47 Direct Compression, 45 Controlled & Modified Release, 44 Taste Masking, 34 Granulation, 33 Solubilizers, 28 Thickeners and Stabilizers, 25 Lubricants & Glidants, 25 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 17 Parenteral, 15 Topical, 7 API Stability Enhancers, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

DIGITAL CONTENT

42 News #PharmaBuzz

42 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 225 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

11 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	IOL Chemicals and Pharmaceuticals	India	M/s IOL Chemicals and Pharmaceuticals Ltd	WC-0004	Lamotrigine IP/BP/Ph.Eur./USP	2025-02-27	2028-03-17	Village Fatehgarh Channa Mansa Road (Trident Complex), Barnala, District Barnala -148101, Punjab (India)
04/06/2025	Cohance Lifesciences	India	M/s Cohance Lifesciences Limited	WC-0150	Lamotrigine USP/Ph. Eur	2022-07-07	2025-07-21	APIUnit-l,R.SNo50/1,Mukteswarapuram Village, Jaggaiahpet Mandal, NTRDistrict-521457, AndhraPradesh, India

Lamitor

Lamitor

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

78 API Suppliers

33 USDMF

22 CEP/COS

5 JDMF

21 EU WC

9 KDMF

21 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1067 FDF Dossiers

230 FDA Orange Book

597 Europe

38 Canada

58 Australia

72 South Africa

72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG

TABLET;ORAL - 150MG

TABLET;ORAL - 200MG

TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 25MG

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

10 Evonik

5 Rochem International Inc

23 SPI Pharma

8 DKSH

1 Pharm-RX Chemical

8 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 ACG Worldwide

8 Actylis

3 Aeon Procare

3 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

38 BASF

1 Bioplus Life Sciences

1 Clariant

16 Corel Pharma Chem

7 DFE Pharma

4 Doshion Polyscience

1 Finar

13 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

12 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

40 Kerry

3 Kima Chemical

6 Lonza Capsugel

20 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

5 Novo Excipients

5 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

23 Roquette

14 Seppic

9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

TABLET;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons